Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It o...
Paper Gains From Research Monkey Valuations Lift Joinn's Profit
Xbrane Biopharma Q2 FY26 net loss widens to SEK 11.4 million; revenue rises to SEK 46.8 million
STOCKS | Zhaoyan New Drug Warns of Overheated Sentiment and Irrational Speculation Risk
JOINN Extends Gains to Over 24%; BOCI Says 1H26 Profit Alert Beats Expectations
JOINN Surges Over 7%; Interim Profit Expected to Jump Up to 13.77x to RMB900 Million
JOINN Laboratories Flags Surging Interim Profit on Biological Asset Gains